SRS Capital Advisors »

Compass Therapeutics shares owned by SRS Capital Advisors

Quarter-by-quarter ownership of Compass Therapeutics (CMPX) shares owned by SRS Capital Advisors from 13F filings

Historical chart of SRS Capital Advisors investment in Compass Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Compass Therapeutics held by SRS Capital Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Compass Therapeutics by SRS Capital Advisors

Quarter filed Position value Share count Share price at filing
2025-09-30 $787 225 3.50

More positions owned by SRS Capital Advisors

Vanguard Index Fds Growth Etf (VOO)
Ishares Tr Ishs 1-5yr Invs (OEF)
First Tr Exchange-traded Wtr Etf (FDL)
American Centy Etf Tr Us Large Cap Vlu (KORP)
Dimensional Etf Trust Intl Core Equity (DFAI)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Apple (AAPL)
Schwab Strategic Tr Us Tips Etf (SCHB)
Microsoft Corporation (MSFT)
First Tr Exchng Traded Fd Vi Smith Opport Fxd (FIXD)
First Tr Exchange Traded Risng Divd Achiv (FXN)
NVIDIA Corporation (NVDA)
First Tr Exch Traded Fd Iii Pfd Secs Inc Etf (FPE)
Spdr S&p 500 Etf Tr Tr Unit
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)

View all positions for SRS Capital Advisors

Top funds holding Compass Therapeutics

Tang Capital Management
OrbiMed Advisors
Suvretta Capital Management
Blackstone Group
Vivo Capital
Enavate Sciences GP
BlackRock
Vanguard Group
Adage Capital Partners GP
MPM Oncology Impact Management
BVF
Rock Springs Capital Management
FMR
Millennium Management
State Street Corporation

View all funds holding Compass Therapeutics